Specification: |
The systematic name of Etaracizumab is Immunoglobulin G1 (synthetic mouse NSO cell heavy chain variable region fragment), complex with immunoglobulin G1 (synthetic mouse NSO cell light chain variable region fragment). With the CAS registry number 892553-42-3, it is also named as Vitaxin. The product's classification codes are Treatment of metastatic melanoma; Treatment of metastatic elanoma, prostate cancer; Treatment of prostate cancer. In addition, its molecular formula is C6392H9908N1732O1996S42.
Etaracizumab is a humanized monoclonal antibody. It has been investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer.
|